| 000 | 01834 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517001741.0 | ||
| 264 | 0 | _c20150305 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1524-4563 | ||
| 024 | 7 |
_a10.1161/HYPERTENSIONAHA.114.04670 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSundgren, Nathan C | |
| 245 | 0 | 0 |
_aIgG receptor FcγRIIB plays a key role in obesity-induced hypertension. _h[electronic resource] |
| 260 |
_bHypertension (Dallas, Tex. : 1979) _cFeb 2015 |
||
| 300 |
_a456-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xphysiology |
| 650 | 0 | 4 |
_aC-Reactive Protein _xadverse effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDietary Fats _xtoxicity |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 |
_aHypertension _xetiology |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aInflammation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNitric Oxide _xphysiology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 |
_aReceptors, IgG _xdeficiency |
| 650 | 0 | 4 |
_aSerum Amyloid P-Component _xanalysis |
| 700 | 1 | _aVongpatanasin, Wanpen | |
| 700 | 1 | _aBoggan, Brigid-Meghan D | |
| 700 | 1 | _aTanigaki, Keiji | |
| 700 | 1 | _aYuhanna, Ivan S | |
| 700 | 1 | _aChambliss, Ken L | |
| 700 | 1 | _aMineo, Chieko | |
| 700 | 1 | _aShaul, Philip W | |
| 773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 65 _gno. 2 _gp. 456-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/HYPERTENSIONAHA.114.04670 _zAvailable from publisher's website |
| 999 |
_c24326964 _d24326964 |
||